Objective: To assess the efficacy and safety profile of docetaxel, as a single agent, in the treatment of elderly patients with advanced breast cancer. Methods: Twenty-eight patients, with a ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Both were in patients receiving docetaxel at the 100 mg/m 2 dose ... The median of the 14 patients who responded to treatment was 14.4 months (95% CI 6.0, 22.7). The median time to disease ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...

The docetaxel-based program, with its lead asset CPC634, stands to validate the CriPec technology and improve the treatment of patients with a range of solid tumors. Cristal Therapeutics has put ...

When should Docetaxel not be taken ... Monitor liver blood function and blood counts regularly. Treatment with corticosteroids before starting this medication is recommended.

The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on ...

Treatment relies on a risk stratification strategy where risk groups are identified ... Initial results with gemcitabine (Gem) and mitomycin C (MMC) appeared promising but shortages in MMC led to the ...

ONCOLife proudly presents an exclusive interview with Dr. Iris Kuss, VP and Global Development Lead Oncology at Bayer. In ...

Patients with Lung Cancer who had Exhausted All Other Treatment Options Achieved Prolonged Progression Free Survival Following Treatment with NUC-3373 plus Docetaxel EDINBURGH, United Kingdom, (GLOBE ...